Search Results for: name
CTH Gene Cystathioninuria Genetic Test Cost
The CTH Gene Cystathioninuria Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the CTH gene, which are linked to cystathioninuria, a rare metabolic disorder. This condition is characterized by the abnormal accumulation of cystathionine in the urine due to a deficiency in the enzyme that breaks down this compound. The test is crucial for early detection, allowing for timely intervention and management of the condition to prevent potential complications. Performed at DNA Labs UAE, a leading facility in genetic testing, this test offers a comprehensive analysis of the CTH gene to pinpoint any genetic anomalies that may contribute to cystathioninuria. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed using advanced genetic sequencing technologies to detect mutations. The cost of the CTH Gene Cystathioninuria Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem steep, it reflects the sophisticated technology and expertise required to accurately identify gene mutations. For individuals with a family history of cystathioninuria or related symptoms, this test provides essential genetic insights that can guide healthcare decisions and potentially improve quality of life through personalized management strategies.
CFTR Gene Cystic fibrosis Genetic Test Cost
The CFTR Gene Cystic Fibrosis Genetic Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CFTR gene, which are responsible for causing cystic fibrosis (CF). Cystic fibrosis is a serious genetic disorder that affects the respiratory and digestive systems, leading to severe complications over time. Early detection through genetic testing can significantly impact the management and treatment options available for affected individuals. This test specifically targets the CFTR gene to check for the presence of mutations that are known to cause the condition. By analyzing an individual's DNA, the test can confirm or rule out the genetic basis of cystic fibrosis, offering crucial information for families with a history of the disease or for couples considering starting a family. Priced at 4400 AED, the CFTR Gene Cystic Fibrosis Genetic Test at DNA Labs UAE is conducted in a state-of-the-art facility, ensuring accuracy and reliability of results. The test is recommended for individuals with a family history of cystic fibrosis, newborns and children displaying symptoms of CF, and couples undergoing genetic counseling before conception. The result from this test can provide valuable insights into treatment strategies, preventive measures, and help in making informed decisions about family planning.
SLC25A1 Gene Combined D-2- and L-2-hydroxyglutaric aciduria Genetic Test Cost
The SLC25A1 Gene Combined D-2- and L-2-hydroxyglutaric aciduria Genetic Test is a specialized diagnostic tool designed to detect mutations in the SLC25A1 gene, which have been associated with the development of combined D-2- and L-2-hydroxyglutaric acidurias. These conditions are rare genetic disorders characterized by the accumulation of D-2-hydroxyglutaric acid and L-2-hydroxyglutaric acid in the body, leading to a variety of clinical symptoms including developmental delay, seizures, and abnormalities in the brain. The test is conducted by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 3200 AED, offering a crucial resource for individuals seeking a precise diagnosis for these specific metabolic disorders. By identifying mutations in the SLC25A1 gene, the test enables healthcare providers to establish a definitive diagnosis, thereby facilitating appropriate treatment and management plans for affected individuals.
ACSF3 Gene Combined malonic and methylmalonic aciduria Genetic Test Cost
The ACSF3 gene combined malonic and methylmalonic aciduria genetic test is a specialized diagnostic tool designed to identify mutations in the ACSF3 gene, which are associated with the rare metabolic disorder known as combined malonic and methylmalonic aciduria (CMAMMA). This condition is characterized by the accumulation of malonic acid and methylmalonic acid in the body, leading to a range of clinical manifestations such as developmental delays, metabolic crises, and various organ dysfunctions. Early detection through genetic testing is crucial for the management and treatment of the disorder. The test involves the collection of a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in a laboratory setting to detect any mutations in the ACSF3 gene. It is a critical step for families with a history of the disorder or for individuals presenting symptoms suggestive of CMAMMA, enabling healthcare providers to make informed decisions about treatment plans and to offer genetic counseling. Performed at DNA Labs UAE, a leading facility in genetic testing, the cost of the ACSF3 gene combined malonic and methylmalonic aciduria genetic test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable test results. This test represents a significant advancement in the field of metabolic disorders, offering hope and support to affected individuals and their families.
GFM1 Gene Combined oxidative phosphorylation deficiency type 1 Genetic Test Cost
The GFM1 gene plays a crucial role in the process of oxidative phosphorylation, a vital mechanism for energy production within cells. Mutations in the GFM1 gene can lead to combined oxidative phosphorylation deficiency type 1, a rare genetic disorder that affects multiple systems in the body, leading to severe clinical manifestations, including lactic acidosis, neurological deficits, and failure to thrive. The genetic test for identifying mutations in the GFM1 gene is a critical tool for diagnosing combined oxidative phosphorylation deficiency type 1. This test involves analyzing the patient's DNA to look for specific alterations in the GFM1 gene that are known to cause the disorder. Early diagnosis through genetic testing is essential for managing symptoms, implementing appropriate treatments, and providing genetic counseling to affected families. In the UAE, DNA Labs offers this specialized genetic test for the GFM1 gene. The test cost is set at 3200 AED, reflecting the intricate processes and sophisticated technology involved in accurately detecting mutations within the gene. By choosing DNA Labs UAE for this test, patients and healthcare providers can expect reliable results, which are crucial for making informed decisions regarding the management of combined oxidative phosphorylation deficiency type 1.
MTO1 Gene Combined oxidative phosphorylation deficiency type 10 Genetic Test Cost
The MTO1 gene plays a crucial role in mitochondrial function, specifically in the process of oxidative phosphorylation, which is essential for producing energy in cells. Mutations in the MTO1 gene can lead to Combined Oxidative Phosphorylation Deficiency Type 10 (COXPD10), a rare genetic disorder that affects multiple systems in the body, leading to a range of symptoms such as muscle weakness, heart problems, and developmental delays. To diagnose this condition, a genetic test targeting the MTO1 gene can be conducted. This test involves analyzing the DNA to identify mutations in the MTO1 gene that are responsible for COXPD10. In the UAE, DNA Labs offers this specific genetic test. The cost of the MTO1 gene test at DNA Labs UAE is 4400 AED. This test is crucial for the early diagnosis and management of COXPD10, allowing for a better understanding of the condition and the possibility of tailored treatments to manage symptoms and improve quality of life for affected individuals.
RMND1 Gene Combined oxidative phosphorylation deficiency type 11 Genetic Test Cost
The RMND1 gene plays a crucial role in the proper functioning of mitochondria, the energy-producing organelles within cells. Mutations in the RMND1 gene can lead to Combined Oxidative Phosphorylation Deficiency Type 11 (COXPD11), a rare genetic disorder that affects multiple body systems and can result in a wide range of health issues, including developmental delay, muscle weakness, hearing loss, and problems with the heart, liver, and brain. To diagnose this condition accurately, genetic testing for mutations in the RMND1 gene is essential. DNA Labs UAE offers a specialized genetic test to identify mutations in the RMND1 gene, aiding in the diagnosis of COXPD11. This test is crucial for understanding the specific genetic alterations in affected individuals, allowing for tailored management and treatment plans. The cost of the RMND1 gene test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect any mutations in the RMND1 gene that could be responsible for the development of COXPD11. By choosing DNA Labs UAE for this genetic test, individuals can expect a high level of accuracy, expertise, and support throughout the testing process, enabling informed decisions about health and treatment options.
EARS2 Gene Combined oxidative phosphorylation deficiency type 12 Genetic Test Cost
The EARS2 gene is associated with combined oxidative phosphorylation deficiency type 12, a rare genetic disorder that affects mitochondrial function, leading to a range of symptoms including developmental delay, muscle weakness, and neurological problems. Testing for mutations in the EARS2 gene can be crucial for diagnosing this condition, guiding treatment options, and providing information on the genetic risk for family members. At DNA Labs UAE, a genetic test is available for identifying mutations in the EARS2 gene. The cost of the test is 4400 AED. This test involves analyzing the patient's DNA to look for specific mutations in the EARS2 gene that are known to cause combined oxidative phosphorylation deficiency type 12. The process is conducted in a state-of-the-art laboratory setting by experienced geneticists and technicians, ensuring accurate and reliable results. The test is recommended for individuals who exhibit symptoms suggestive of mitochondrial disorders or have a family history of such conditions. Early detection through genetic testing can be instrumental in managing the condition more effectively and improving the quality of life for those affected.